|
Market Closed -
Nasdaq
00:30:00 12/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 18.45 USD | -0.67% |
|
-1.60% | +94.42% |
| 08-14 | Fortress Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-13 | Fortress Biotech, Inc., Q2 2026 Earnings Call, Aug 12, 2026 |
Company Valuation: Fortress Biotech, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 249.1 | 71.14 | 54.57 | 55.9 | 113.6 | 84.04 | - |
| Change | - | -71.44% | -23.29% | 2.43% | 103.22% | -26.02% | - |
| Enterprise Value (EV) | 249.1 | 71.14 | 54.57 | 55.9 | 113.6 | 84.04 | 84.04 |
| Change | - | -71.44% | -23.29% | 2.43% | 103.22% | -26.02% | 0% |
| P/E | -3.16x | -0.68x | -0.36x | -0.75x | -52.3x | 0.99x | -2.52x |
| PBR | - | - | - | - | - | - | - |
| PEG | - | -0x | 0x | 0x | 0.5x | -0x | 0x |
| Capitalization / Revenue | 3.62x | 0.94x | 0.65x | 0.97x | 1.8x | 1.07x | 0.74x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 1.07x | 0.74x |
| EV / EBITDA | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -2.55x | -5.22x |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | -11.85 | -14.55 | -8.47 | -2.69 | -0.07 | 2.55 | -1 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | 68.79 | 75.74 | 84.51 | 57.68 | 63.26 | 78.79 | 113.2 |
| EBITDA | -188.5 | - | - | -107.3 | -65.56 | - | - |
| EBIT 1 | -188.5 | -203.6 | -142.3 | -110.4 | -70.22 | -32.9 | -16.11 |
| Net income 1 | -64.7 | -86.58 | -68.67 | -46 | -1.882 | 88.25 | -37.81 |
| Net Debt | - | - | - | - | - | - | - |
| Reference price 2 | 37.500 | 9.825 | 3.010 | 2.025 | 3.660 | 2.520 | 2.520 |
| Nbr of stocks (in thousands) | 6,642 | 7,241 | 18,131 | 27,605 | 31,038 | 33,351 | - |
| Announcement Date | 28/03/22 | 30/03/23 | 28/03/24 | 31/03/25 | 31/03/26 | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 18.1x | 4.19x | 9.84x | 0.5% | 78.02B | |
| 19.65x | 4.21x | 13.08x | 2.5% | 57.4B | |
| -17.17x | 25.62x | -16.63x | -.--% | 57.48B | |
| 34.47x | 11.73x | 22.49x | -.--% | 48.81B | |
| 20.54x | 4.54x | 12.95x | 0.71% | 45.5B | |
| 37.49x | 3.54x | 13.51x | -.--% | 32.08B | |
| 54.21x | 3.43x | 26.59x | -.--% | 24.62B | |
| 62.21x | 6.52x | 39.5x | -.--% | 20.77B | |
| 22.98x | 4.94x | 12.86x | -.--% | 15.75B | |
| Average | 28.05x | 7.64x | 14.91x | 0.41% | 42.27B | |
| Weighted average by Cap. | 21.98x | 8.49x | 11.46x | 0.56% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- FBIO Stock
- FBIOP Stock
- Valuation Fortress Biotech, Inc.
Select your edition
All financial news and data tailored to specific country editions
